Clinical trial of fibrinselective thrombolytic pharmaceutical agent "FORTELYZIN®" (III Phase) the comparative efficacy and safety with Actilyse® in patients with acute
myocardial infarction and obtained data
LIFE QUALITY OF MYOCARDIAL INFARCTION PATIENTS ACCORDING TO THE PRESENCE OF TYPE D PERSONALITYElvira, Mutalova G.,
Velena, Galyautdinova R.,
Gulnara, Kamaltdinova J.,
Liana, Samigullina I.,
МУТАЛОВА, Э.Г.,
ГАЛЯУТДИНОВА, В.Р.,
КАМАЛТДИНОВА, Г.Я.,
САМИГУЛЛИНА, Л.И. возраст 58,2±2,5 года, поступивших в стационар по поводу инфаркта миокарда с подъемом сегмента
ST. Диагноз
Pharmacoeconomical basis for the use of ACE inhibitors after myocardial infarctionPharmacoeconomical basis for the use of ACE inhibitors after
myocardial infarction RELATIONSHIP OF TYPE D PERSONALITY AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTIONGalyautdinova, Velena R.,
Mutalova, Elvira G.,
Nigmatullina, Albina E.,
Samigullina, Liana I.,
ГАЛЯУТДИНОВА, В.Р.,
МУТАЛОВА, Э.Г.,
САМИГУЛЛИНА, Л.И.,
НИГМАТУЛЛИНА, А.Э. сегмента
ST. Диагноз устанавливался согласно клиническим рекомендациям Российского кардиологического
Acute coronary syndrome in elderly: Current status and unresolved issues efficacy, and complications of reperfusion therapy in ACS with
ST elevation (STEMI) in the senile